News
Clinical Trials Arena on MSN7d
Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trialThe trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback